Cargando…
Preclinical and clinical evidence for the treatment of non-alcoholic fatty liver disease with soybean: A systematic review and meta-analysis
Non-alcoholic fatty liver disease (NAFLD), a prevalent public health issue, involves the accumulation of triglycerides in hepatocytes, which is generally considered to be an early lesion of liver fibrosis and cirrhosis. Thus, the development of treatments for NAFLD is urgently needed. This study exp...
Autores principales: | Li, Yubing, Deng, Xinyu, Guo, Xiaochuan, Zhang, Fangling, Wu, Hefei, Qin, Xuhua, Ma, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907442/ https://www.ncbi.nlm.nih.gov/pubmed/36762106 http://dx.doi.org/10.3389/fphar.2023.1088614 |
Ejemplares similares
-
Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses
por: He, Xuan, et al.
Publicado: (2023) -
Preclinical Evidence of Berberine on Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Animal Studies
por: Ren, Sichen, et al.
Publicado: (2021) -
Therapeutic Opportunities of GPBAR1 in Cholestatic Diseases
por: Zhang, Fangling, et al.
Publicado: (2022) -
Lipophagy and Alcohol-Induced Fatty Liver
por: Yang, Li, et al.
Publicado: (2019) -
Paeoniflorin Protects against Acetaminophen-Induced Liver Injury in Mice via JNK Signaling Pathway
por: Deng, Xinyu, et al.
Publicado: (2022)